Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerlach

Showing results (251-260 of 352) with videos related to

Pageof 36
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactamM A Pfaller, A L Barry, P C Fuchs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Nature|December 4, 1986
Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceJ H Gerlach, J A Endicott, P F Juranka, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Intensive Care Medicine|January 7, 1999
Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitriteM Gerlach, D Keh, G Bezold, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroximeJ A Washington, R N Jones, E H Gerlach, et al.
Pageof 36

Showing results (251-260 of 352) with videos related to

Sort By:
Pageof 36
Antimicrobial Agents and Chemotherapy|January 1, 1992
Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family EnterobacteriaceaeA L Barry, P C Fuchs, E H Gerlach, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1993
Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactamM A Pfaller, A L Barry, P C Fuchs, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosaD J Hardy, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.
Nature|December 4, 1986
Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceJ H Gerlach, J A Endicott, P F Juranka, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1993
Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteriaP R Murray, R N Jones, S D Allen, et al.
Intensive Care Medicine|January 7, 1999
Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitriteM Gerlach, D Keh, G Bezold, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroximeJ A Washington, R N Jones, E H Gerlach, et al.
Pageof 36